VIM and cervical carcinoma: Additional cancers witness vimentin overexpression [3] including certain types of lymphomas [275], endometrial carcinomas [276], papillary thyroid carcinomas [277], cervical cancers [278], clear-cell renal-cell carcinomas [279], and central nervous system tumours [280,281].